Jay M. Haft, Director at DUSA PHARMACEUTICALS INC (DUSA), bought 10,000 shares at $1.72 ($17K) on 2010-03-05, disclosed to the SEC on 2010-03-08.
Open-market purchase of $17k DUSA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| KINS | SELL | 2017-02-15 | $1.0M | — | Filing → |
| KINS | SELL | 2017-02-01 | $874K | — | Filing → |
| DUSA | BUY | 2011-08-10 | $12K | — | Filing → |